title: Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.
authors.affiliation: Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK National Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK ddenning@manchester.ac.uk.
authors.forename: David W
authors.initials: DW
authors.lastname: Denning
authors.affiliation: Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.
authors.forename: Nesrin
authors.initials: N
authors.lastname: Ghnan
authors.affiliation: Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Kwizera
authors.affiliation: Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.
authors.forename: Ali
authors.initials: A
authors.lastname: Osmanov
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D001228:Aspergillosis / Q000188:drug therapy*; D001232:Aspergillus fumigatus / Q000187:drug effects*; D006801:Humans; D065819:Voriconazole / Q000494:pharmacology*
chemical_list: D000935:Antifungal Agents; D065819:Voriconazole
keywords: A. fumigatus; fungicidal; paediatrics